Riskpilot← Back to searchSign inGet full accessVitalabs AB
ABActiveOrg 5594099276Botulfsgatan 2Business and other management consultancy activities · NACE 7020Est. 20220 employees
Revenue 2024
SEK -1
-200% vs 2023
EBITDA margin
220371300.0%
-48% vs 2023
Equity ratio
86.9%
Financial strength
Net profit 2024
SEK -2,2M
-47% vs 2023
| Revenue | SEK -1 | -200% |
| EBITDA | SEK -2,2M | -48% |
| Net profit | SEK -2,2M | -47% |
| Total assets | SEK 3,6M | -30% |
| Equity | SEK 3,1M | +216% |
| Employees | 0 | — |
Legal name
Vitalabs AB
Org number
5594099276
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 december 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Styrelsen ska bestå av 3 styrelseledamöter och 0 styrelsesuppleanter. Registrerad styrelseordförande saknas.
Company purpose
Föremålet för bolagets verksamhet är att direkt eller indirekt äga och förvalta aktier, värdepapper och fastigheter samt annan fast och lös egendom och därmed förenlig verksamhet.
Address
Botulfsgatan 2
Email
ingela.mauritzon@invitrovista.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | −0 |
| Staff expenses | −870 | −1 079 |
| EBITDA | −1 494 | −2 204 |
| Depreciation & amort. | — | — |
| EBIT | −1 494 | −2 204 |
| Net financials | −1 | 5 |
| Profit before tax | −1 495 | −2 199 |
| Tax | — | — |
| Net profit | −1 495 | −2 199 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 5 156 | 3 622 |
| Equity | 998 | 3 149 |
| Long-term debt | 1 525 | 0 |
| Short-term debt | 2 633 | 473 |
| Total debt | 4 158 | 473 |
EBITDA margin
-220371300.0%
This company
15.8%
Market median
-1394755163% vs market
20232024
Equity ratio
86.9%
This company
38.2%
Market median
+127% vs market
20232024
Return on equity
-69.8%
This company
18.4%
Market median
-479% vs market
20232024
Net profit margin
-219917300.0%
This company
8.1%
Market median
-2715028495% vs market
20232024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20232024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-05 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CM External Signatory | External Signatory | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kasbi Holding AB | Company | 51.0% | 51.0% | 2025 |
Firehill Holding AB | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kasbi Holding AB
Vitalabs AB Board members of Vitalabs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Magnus Rosengren | External Signatory | 0 companies |
| Ingela Christina Mauritzon | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Mack-Kalevi Palomäki | Board of Directors | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |
| Ashkan Kasbi | Chairman | 0 companies |